Tudor Investment Corp
CBAY

Tudor Investment Corp’s Cymabay Therapeutics CBAY Stock Holding History

Tudor Investment Corp’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-24,769
Closed -$369K – 3012
2023
Q3 		$369K Buy
+24,769
New +$328K ﹤0.01% 1830
2020
Q1 		– Sell
-21,512
Closed -$42K – 1395
2019
Q4 		$42K Buy
+21,512
New +$80.8K ﹤0.01% 1094
2017
Q4 		– Sell
-15,978
Closed -$129K – 1325
2017
Q3 		$129K Buy
+15,978
New +$108K ﹤0.01% 1002

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tudor Investment Corp's CBAY Position: Q4 2023 in Review

Tudor Investment Corp sold out of Cymabay Therapeutics (CBAY) in Q4 2023, closing a stake of 24,769 shares — an estimated $369K sold.

Tudor Investment Corp first reported a position in CBAY in Q3 2017 and held it in 3 quarters. The position peaked at $369K in Q3 2023. 200 funds tracked by Wall St. Rank hold CBAY as of Q4 2023.

  • Tudor Investment Corp reported no remaining Cymabay Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Tudor Investment Corp sold 24,769 Cymabay Therapeutics shares in Q4 2023, an estimated $369K.
  • Tudor Investment Corp first reported a position in Cymabay Therapeutics in Q3 2017 and held it in 3 quarters.
  • Tudor Investment Corp's Cymabay Therapeutics position peaked at $369K in Q3 2023.
  • 200 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q4 2023.

Based on Tudor Investment Corp's 13F filing for Q4 2023, filed 14 Feb 2024.